# Chemours Co (CC) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from Chemours Co's 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2025 MD&A](/company/CC/mda/fy2025/): filed 2026-02-24; accession 0001193125-26-065201 (https://www.sec.gov/Archives/edgar/data/1627223/000119312526065201/cc-20251231.htm); latest 10-K
- [FY 2024 MD&A](/company/CC/mda/fy2024/): filed 2025-02-18; accession 0000950170-25-021787 (https://www.sec.gov/Archives/edgar/data/1627223/000095017025021787/cc-20241231.htm)
- [FY 2023 MD&A](/company/CC/mda/fy2023/): filed 2024-03-27; accession 0000950170-24-037171 (https://www.sec.gov/Archives/edgar/data/1627223/000095017024037171/cc-20231231.htm)
- [FY 2022 MD&A](/company/CC/mda/fy2022/): filed 2023-02-10; accession 0000950170-23-002467 (https://www.sec.gov/Archives/edgar/data/1627223/000095017023002467/cc-20221231.htm)
- [FY 2021 MD&A](/company/CC/mda/fy2021/): filed 2022-02-11; accession 0001564590-22-004791 (https://www.sec.gov/Archives/edgar/data/1627223/000156459022004791/cc-10k_20211231.htm)

Back to /company/CC/